Natriuretic peptides and their receptors in the central nervous system

Progress in Neurobiology

Volumn 84, Issue 3, 2008, Pages 234-248

  Cao, Li Hui ^a   Yang, Xiong Li ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Central nervous system; Intracellular mechanism; Natriuretic peptide; Natriuretic peptide receptor

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE RECEPTOR C; NATRIURETIC PEPTIDE TYPE C; NEUROTRANSMITTER;

CENTRAL NERVOUS SYSTEM; CEREBELLUM; CHEMICAL STRUCTURE; ENZYME REGULATION; HYPOTHALAMUS; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NEUROTRANSMITTER UPTAKE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA; REVIEW; SYNAPTIC TRANSMISSION; TELENCEPHALON;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CENTRAL NERVOUS SYSTEM; HUMANS; NATRIURETIC PEPTIDES;

EID: 39149119277     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2007.12.003     Document Type: Review

References (219)

1. Abdelalim E.M., Osman A.H., Takada T., Torii R., and Tooyama I. Immunohistochemical mapping of natriuretic peptide receptor-A in the brainstem of Macaca fascicularis. Neuroscience 145 (2007) 1087-1096
2. Abdelalim E.M., Takada T., Torii R., and Tooyama I. Molecular cloning of BNP from heart and its immunohistochemical localization in the hypothalamus of monkey. Peptides 27 (2006) 1886-1893
3. Abell T.J., Richards A.M., Ikram H., Espiner E.A., and Yandle T. Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor. Biochem. Biophys. Res. Commun. 160 (1989) 1392-1396
4. Akamatsu N., Inenaga K., and Yamashita H. Inhibitory effects of natriuretic peptides on vasopressin neurons mediated through cGMP and cGMP-dependent protein kinase in vitro. J. Neuroendocrinol. 5 (1993) 517-522
5. Anand-Srivastava M.B. Natriuretic peptide receptor-C signaling and regulation. Peptides 26 (2005) 1044-1059
6. Anand-Srivastava M.B., Sairam M.R., and Cantin M. Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system. J. Biol. Chem. 265 (1990) 8566-8572
7. Anand-Srivastava M.B., Sehl P.D., and Lowe D.G. Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase. Involvement of a pertussis toxin-sensitive G protein. J. Biol. Chem. 271 (1996) 19324-19329
8. Anand-Srivastava M.B., and Trachte G.J. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol. Rev. 45 (1993) 455-497
9. Anderson J.V., Struthers A.D., Payne N.N., Slater J.D., and Bloom S.R. Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man. Clin. Sci. (Lond.) 70 (1986) 507-512
10. Antunes-Rodrigues J., Ramalho M.J., Reis L.C., Picanco-Diniz D.W., Favaretto A.L., Gutkowska J., and McCann S.M. Possible role of endothelin acting within the hypothalamus to induce the release of atrial natriuretic peptide and natriuresis. Neuroendocrinology 58 (1993) 701-708
11. Appel R.G. Growth inhibitory activity of atrial natriuretic factor in rat glomerular mesangial cells. FEBS Lett. 238 (1988) 135-138
12. Babinski K., Haddad P., Vallerand D., McNicoll N., de Lean A., and Ong H. Natriuretic peptides inhibit nicotine-induced whole-cell currents and catecholamine secretion in bovine chromaffin cells: evidence for the involvement of the atrial natriuretic factor R2 receptors. J. Neurochem. 64 (1995) 1080-1087
13. Baldissera S., Menani J.W., dos Santos L.F., Favaretto A.L., Gutkowska J., Turrin M.Q., McCann S.M., and Antunes-Rodrigues J. Role of the hypothalamus in the control of atrial natriuretic peptide release. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 9621-9625
14. Barger S.W., Fiscus R.R., Ruth P., Hofmann F., and Mattson M.P. Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of beta-amyloid precursor. J. Neurochem. 64 (1995) 2087-2096
15. Beaumont K., and Tan P.K. Effects of atrial and brain natriuretic peptides upon cyclic GMP levels, potassium transport, and receptor binding in rat astrocytes. J. Neurosci. Res. 25 (1990) 256-262
16. Berl T., Mansour J., and Teitelbaum I. ANP stimulates phospholipase C in cultured RIMCT cells: roles of protein kinases and G protein. Am. J. Physiol. 260 (1991) F590-F595
17. Blute T.A., Lee H.K., Huffmaster T., Haverkamp S., and Eldred W.D. Localization of natriuretic peptides and their activation of particulate guanylate cyclase and nitric oxide synthase in the retina. J. Comp. Neurol. 424 (2000) 689-700
18. Brown J., and Zuo Z. Natriuretic peptide receptors are expressed during cerebral growth in the fetal rat. Am. J. Physiol. 269 (1995) R261-R273
19. Cao L.H., and Yang X.L. Natriuretic peptide receptor-A is functionally expressed on bullfrog retinal Müller cells. Brain Res. Bull. 71 (2007) 410-415
20. Cao L.H., Yu Y.C., Zhao J.W., and Yang X.L. Expression of natriuretic peptides in rat Müller cells. Neurosci. Lett. 365 (2004) 176-179
21. Cea L.B. Natriuretic peptide family: new aspects. Curr. Med. Chem. Cardiovasc. Hematol. Agents 3 (2005) 87-98
22. Chinkers M., and Garbers D.L. The protein kinase domain of the ANP receptor is required for signaling. Science 245 (1989) 1392-1394
23. Chinkers M., Garbers D.L., Chang M.S., Lowe D.G., Chin H.M., Goeddel D.V., and Schulz S. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 338 (1989) 78-83
24. Chinkers M., Singh S., and Garbers D.L. Adenine nucleotides are required for activation of rat atrial natriuretic peptide receptor/guanylyl cyclase expressed in a baculovirus system. J. Biol. Chem. 266 (1991) 4088-4093
25. Chriguer R.S., Rocha M.J., Antunes-Rodrigues J., and Franci C.R. Hypothalamic atrial natriuretic peptide and secretion of oxytocin. Brain Res. 889 (2001) 239-242
26. Currie M.G., Geller D.M., Cole B.R., Siegel N.R., Fok K.F., Adams S.P., Eubanks S.R., Galluppi G.R., and Needleman P. Purification and sequence analysis of bioactive atrial peptides (atriopeptins). Science 223 (1984) 67-69
27. de Bold A.J., Borenstein H.B., Veress A.T., and Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 28 (1981) 89-94
28. de Louw A.J., de Vente J., Steinbusch H.P., Steinbusch H.W., Troost J., and Vles J.S. Baclofen inhibits ANP-mediated cyclic GMP synthesis in the rat cervical spinal cord. Neurosci. Lett. 321 (2002) 120-122
29. de Vente J., Bol J.G., and Steinbusch H.W. cGMP-producing, atrial natriuretic factor-responding cells in the rat brain. Eur. J. Neurosci. 1 (1989) 436-460
30. de Vente J., Manshanden C.G., Sikking R.A., Ramaekers F.C., and Steinbusch H.W. A functional parameter to study heterogeneity of glial cells in rat brain slices: cyclic guanosine monophosphate production in atrial natriuretic factor (ANF)-responsive cells. Glia 3 (1990) 43-54
31. de Vente J., Markerink-van Ittersum M., and Vles J.S. ANP-mediated cGMP signaling and phosphodiesterase inhibition in the rat cervical spinal cord. J. Chem. Neuroanat. 31 (2006) 263-274
32. Delay R.J., Dubin A.E., and Dionne V.E. A cyclic nucleotide-dependent chloride conductance in olfactory receptor neurons. J. Membr. Biol. 159 (1997) 53-60
33. DiCicco-Bloom E., Lelievre V., Zhou X., Rodriguez W., Tam J., and Waschek J.A. Embryonic expression and multifunctional actions of the natriuretic peptides and receptors in the developing nervous system. Dev. Biol. 271 (2004) 161-175
34. Drewett J.G., Ziegler R.J., and Trachte G.J. Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells. J. Pharmacol. Exp. Ther. 255 (1990) 497-503
35. Duda T., Goraczniak R.M., and Sharma R.K. Site-directed mutational analysis of a membrane guanylate cyclase cDNA reveals the atrial natriuretic factor signaling site. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7882-7886
36. Duda T., and Sharma R.K. ATP bimodal switch that regulates the ligand binding and signal transduction activities of the atrial natriuretic factor receptor guanylate cyclase. Biochem. Biophys. Res. Commun. 209 (1995) 286-292
37. Duda T., Venkataraman V., Ravichandran S., and Sharma R.K. ATP-regulated module (ARM) of the atrial natriuretic factor receptor guanylate cyclase. Peptides 26 (2005) 969-984
38. Eigenthaler M., Lohmann S.M., Walter U., and Pilz R.B. Signal transduction by cGMP-dependent protein kinases and their emerging roles in the regulation of cell adhesion and gene expression. Rev. Physiol. Biochem. Pharmacol. 135 (1999) 173-209
39. Evrard A., Hober C., Racadot A., Lefebvre J., and Vantyghem M.C. Atrial natriuretic hormone and endocrine functions. Ann. Biol. Clin. (Paris) 57 (1999) 149-155
40. Fan D., Bryan P.M., Antos L.K., Potthast R.J., and Potter L.R. Down-regulation does not mediate natriuretic peptide-dependent desensitization of natriuretic peptide receptor (NPR)-A or NPR-B: guanylyl cyclase-linked natriuretic peptide receptors do not internalize. Mol. Pharmacol. 67 (2005) 174-183
41. Fenrick R., Bouchard N., McNicoll N., and De Lean A. Glycosylation of asparagine 24 of the natriuretic peptide receptor-B is crucial for the formation of a competent ligand binding domain. Mol. Cell. Biochem. 173 (1997) 25-32
42. Fernandez B.E., Dominguez A.E., Vatta M.S., Mendez M.A., Bianciotti L.G., and Martinez Seeber A. Atrial natriuretic peptide and angiotensin II interaction on noradrenaline uptake in the central nervous system. Arch. Int. Pharmacodyn. Ther. 307 (1990) 11-17
43. Fiscus R.R., Tu A.W., and Chew S.B. Natriuretic peptides inhibit apoptosis and prolong the survival of serum-deprived PC12 cells. Neuroreport 12 (2001) 185-189
44. Forloni G., Lucca E., Angeretti N., Chiesa R., and Vezzani A. Neuroprotective effect of somatostatin on nonapoptotic NMDA-induced neuronal death: role of cyclic GMP. J. Neurochem. 68 (1997) 319-327
45. Foster D.C., and Garbers D.L. Dual role for adenine nucleotides in the regulation of the atrial natriuretic peptide receptor, guanylyl cyclase-A. J. Biol. Chem. 273 (1998) 16311-16318
46. Fowkes R.C., Forrest-Owen W., and McArdle C.A. C-type natriuretic peptide (CNP) effects in anterior pituitary cell lines: evidence for homologous desensitisation of CNP-stimulated cGMP accumulation in alpha T3-1 gonadotroph-derived cells. J. Endocrinol. 166 (2000) 195-203
47. Francis S.H., and Corbin J.D. Progress in understanding the mechanism and function of cyclic GMP-dependent protein kinase. Adv. Pharmacol. 26 (1994) 115-170
48. Friedl A., Harmening C., Schmalz F., Schuricht B., Schiller M., and Hamprecht B. Elevation by atrial natriuretic factors of cyclic GMP levels in astroglia-rich cultures from murine brain. J. Neurochem. 52 (1989) 589-597
49. Fujio N., Ohashi M., Nawata H., Kato K., Tateishi J., Matsuo H., and Ibayashi H. Unique distributions of natriuretic hormones in dog brain. Regul. Pept. 18 (1987) 131-137
50. Fuller F., Porter J.G., Arfsten A.E., Miller J., Schilling J.W., Scarborough R.M., Lewicki J.A., and Schenk D.B. Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones. J. Biol. Chem. 263 (1988) 9395-9401
51. Garbers D.L. Guanylyl cyclase-linked receptors. Pharmacol. Ther. 50 (1991) 337-345
52. Garcia de Lacoba M., Fernandez-Durango R., Trivino A., Ramirez J.M., Ramirez A.I., Salazar J.J., Fernandez-Cruz A., and Gutkowska J. Existence of atrial natriuretic peptide in choroid, retina and ciliary body in rabbits. Rev. Esp. Fisiol. 47 (1991) 91-96
53. Gazzano H., Wu H.I., and Waldman S.A. Adenine nucleotide regulation of particulate guanylate cyclase from rat lung. Biochim. Biophys. Acta 1077 (1991) 99-106
54. Gibson T.R., Wildey G.M., Manaker S., and Glembotski C.C. Autoradiographic localization and characterization of atrial natriuretic peptide binding sites in the rat central nervous system and adrenal gland. J. Neurosci. 6 (1986) 2004-2011
55. Goncalves J., Grove K.L., and Deschepper C.F. Generation of cyclic guanosine monophosphate in brain slices incubated with atrial or C-type natriuretic peptides: comparison of the amplitudes and cellular distribution of the responses. Regul. Pept. 57 (1995) 55-63
56. Goraczniak R.M., Duda T., and Sharma R.K. A structural motif that defines the ATP-regulatory module of guanylate cyclase in atrial natriuretic factor signalling. Biochem. J. 282 Pt 2 (1992) 533-537
57. Guedon J. Control of the excretion of sodium and natriuretic hormones. Rev. Prat. 36 (1986) 2088-2095
58. Gutkowska J., Tremblay J., Meyer R., Marcinkiewicz M., and Nemer M. Evidence for atrial natriuretic peptide (ANP) synthesis and the presence of ANP-transducing receptors in the rat olfactory bulb. J. Neurochem. 57 (1991) 1855-1861
59. Herman J.P., Dolgas C.M., Marcinek R., and Langub Jr. M.C. Expression and glucocorticoid regulation of natriuretic peptide clearance receptor (NPR-C) mRNA in rat brain and choroid plexus. J. Chem. Neuroanat. 11 (1996) 257-265
60. Herman J.P., Langub Jr. M.C., and Watson Jr. R.E. Localization of C-type natriuretic peptide mRNA in rat hypothalamus. Endocrinology 133 (1993) 1903-1906
61. Horio T., Kohno M., and Takeda T. Effects of arginine vasopressin, angiotensin II and endothelin-1 on the release of brain natriuretic peptide in vivo and in vitro. Clin. Exp. Pharmacol. Physiol. 19 (1992) 575-582
62. Hosli E., and Hosli L. Autoradiographic localization of binding sites for arginine vasopressin and atrial natriuretic peptide on astrocytes and neurons of cultured rat central nervous system. Neuroscience 51 (1992) 159-166
63. Imura H., Nakao K., and Itoh H. The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions. Front. Neuroendocrinol. 13 (1992) 217-249
64. Jacobowitz D.M., Skofitsch G., Keiser H.R., Eskay R.L., and Zamir N. Evidence for the existence of atrial natriuretic factor-containing neurons in the rat brain. Neuroendocrinology 40 (1985) 92-94
65. Jaubert J., Jaubert F., Martin N., Washburn L.L., Lee B.K., Eicher E.M., and Guenet J.L. Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3). Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 10278-10283
66. Jin Y., Zhong Y.M., and Yang X.L. Natriuretic peptides are localized to rat retinal amacrine cells. Neurosci. Lett. 421 (2007) 106-109
67. Johnson A., Lermioglu F., Garg U.C., Morgan-Boyd R., and Hassid A. A novel biological effect of atrial natriuretic hormone: inhibition of mesangial cell mitogenesis. Biochem. Biophys. Res. Commun. 152 (1988) 893-897
68. Joubert S., Jossart C., McNicoll N., and De Lean A. Atrial natriuretic peptide-dependent photolabeling of a regulatory ATP-binding site on the natriuretic peptide receptor-A. Febs J. 272 (2005) 5572-5583
69. Joubert S., Labrecque J., and De Lean A. Reduced activity of the NPR-A kinase triggers dephosphorylation and homologous desensitization of the receptor. Biochemistry 40 (2001) 11096-11105
70. Kaneko T., Shirakami G., Nakao K., Nakagawa O., Hama N., Suga S., Miyamoto S., Kubo H., and Imura H. C-type natriuretic peptide (CNP) is the major natriuretic peptide in human cerebrospinal fluid. Brain Res. 612 (1993) 104-109
71. Kangawa K., and Matsuo H. Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem. Biophys. Res. Commun. 118 (1984) 131-139
72. Kanwal S., Elmquist B.J., and Trachte G.J. Atrial natriuretic peptide inhibits evoked catecholamine release by altering sensitivity to calcium. J. Pharmacol. Exp. Ther. 283 (1997) 426-433
73. Kariya K., Kawahara Y., Araki S., Fukuzaki H., and Takai Y. Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis 80 (1989) 143-147
74. Kashii S., Takahashi M., Mandai M., Shimizu H., Honda Y., Sasa M., Ujihara H., Tamura Y., Yokota T., and Akaike A. Protective action of dopamine against glutamate neurotoxicity in the retina. Invest. Ophthalmol. Vis. Sci. 35 (1994) 685-695
75. Kawahara N., Ruetzler C.A., and Klatzo I. Protective effect of spreading depression against neuronal damage following cardiac arrest cerebral ischaemia. Neurol. Res. 17 (1995) 9-16
76. Kawata M., Hirakawa M., Kumamoto K., Minamino N., Kangawa K., Matsuo H., and Sano Y. Brain natriuretic peptide in the porcine spinal cord: an immunohistochemical investigation of its localization and the comparison with atrial natriuretic peptide, substance P, calcitonin gene-related peptide, and enkephalin. Neuroscience 33 (1989) 401-410
77. Kawata M., Nakao K., Morii N., Kiso Y., Yamashita H., Imura H., and Sano Y. Atrial natriuretic polypeptide: topographical distribution in the rat brain by radioimmunoassay and immunohistochemistry. Neuroscience 16 (1985) 521-546
78. Kim J.H., Yang S.H., Yu M.Y., Lee H.K., Kim S.Y., and Kim S.H. Dendroaspis natriuretic peptide system and its paracrine function in rat colon. Regul. Pept. 120 (2004) 93-98
79. Kitaoka Y., and Kumai T. Modulation of retinal dopaminergic cells by nitric oxide. A protective effect on NMDA-induced retinal injury. In Vivo 18 (2004) 311-315
80. Kitaoka Y., Kumai T., Isenoumi K., Kitaoka Y., Motoki M., Kobayashi S., and Ueno S. Neuroprotective effect of nitric oxide against NMDA-induced neurotoxicity in the rat retina is associated with tyrosine hydroxylase expression. Brain Res. 977 (2003) 46-54
81. Kobayashi H., Mizuki T., Tsutsui M., Minami K., Yanagihara N., Yuhi T., and Izumi F. Receptors for C-type natriuretic peptide in cultured rat glial cells. Brain Res. 617 (1993) 163-166
82. Kobayashi S., Harris V.A., and Welsh F.A. Spreading depression induces tolerance of cortical neurons to ischemia in rat brain. J. Cereb. Blood Flow Metab. 15 (1995) 721-727
83. Koesling D., Bohme E., and Schultz G. Guanylyl cyclases, a growing family of signal-transducing enzymes. Faseb J. 5 (1991) 2785-2791
84. Koh G.Y., Nussenzveig D.R., Okolicany J., Price D.A., and Maack T. Dynamics of atrial natriuretic factor-guanylate cyclase receptors and receptor-ligand complexes in cultured glomerular mesangial and renomedullary interstitial cells. J. Biol. Chem. 267 (1992) 11987-11994
85. Koller K.J., de Sauvage F.J., Lowe D.G., and Goeddel D.V. Conservation of the kinaselike regulatory domain is essential for activation of the natriuretic peptide receptor guanylyl cyclases. Mol. Cell. Biol. 12 (1992) 2581-2590
86. Koller K.J., Lipari M.T., and Goeddel D.V. Proper glycosylation and phosphorylation of the type A natriuretic peptide receptor are required for hormone-stimulated guanylyl cyclase activity. J. Biol. Chem. 268 (1993) 5997-6003
87. Koller K.J., Lowe D.G., Bennett G.L., Minamino N., Kangawa K., Matsuo H., and Goeddel D.V. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252 (1991) 120-123
88. Komatsu Y., Nakao K., Suga S., Ogawa Y., Mukoyama M., Arai H., Shirakami G., Hosoda K., Nakagawa O., and Hama N. C-type natriuretic peptide (CNP) in rats and humans. Endocrinology 129 (1991) 1104-1106
89. Kovacs G.L. Natriuretic peptides in alcohol withdrawal: central and peripheral mechanisms. Curr. Med. Chem. 10 (2003) 2559-2576
90. Krzan M., Stenovec M., Kreft M., Pangrsic T., Grilc S., Haydon P.G., and Zorec R. Calcium-dependent exocytosis of atrial natriuretic peptide from astrocytes. J. Neurosci. 23 (2003) 1580-1583
91. Kumar R., Cartledge W.A., Lincoln T.M., and Pandey K.N. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase. Hypertension 29 (1997) 414-421
92. Kuribayashi K., Kitaoka Y., Kumai T., Munemasa Y., Kitaoka Y., Isenoumi K., Motoki M., Kogo J., Hayashi Y., Kobayashi S., and Ueno S. Neuroprotective effect of atrial natriuretic peptide against NMDA-induced neurotoxicity in the rat retina. Brain Res. 1071 (2006) 34-41
93. Kurihara M., Saavedra J.M., and Shigematsu K. Localization and characterization of atrial natriuretic peptide binding sites in discrete areas of rat brain and pituitary gland by quantitative autoradiography. Brain Res. 408 (1987) 31-39
94. Labrecque J., McNicoll N., Marquis M., and De Lean A. A disulfide-bridged mutant of natriuretic peptide receptor-A displays constitutive activity. Role of receptor dimerization in signal transduction. J. Biol. Chem. 274 (1999) 9752-9759
95. Langenickel T.H., Buttgereit J., Pagel-Langenickel I., Lindner M., Monti J., Beuerlein K., Al-Saadi N., Plehm R., Popova E., Tank J., Dietz R., Willenbrock R., and Bader M. Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 4735-4740
96. Langub Jr. M.C., Dolgas C.M., Watson Jr. R.E., and Herman J.P. The C-type natriuretic peptide receptor is the predominant natriuretic peptide receptor mRNA expressed in rat hypothalamus. J. Neuroendocrinol. 7 (1995) 305-309
97. Leao A. Spreading depression activity in the cerebral cortex. J. Neurophysiol. 7 (1944) 359-390
98. Lefkowitz R.J., Pierce K.L., and Luttrell L.M. Dancing with different partners: protein kinase a phosphorylation of seven membrane-spanning receptors regulates their G protein-coupling specificity. Mol. Pharmacol. 62 (2002) 971-974
99. Lelievre V., Pineau N., Hu Z., Ioffe Y., Byun J.Y., Muller J.M., and Waschek J.A. Proliferative actions of natriuretic peptides on neuroblastoma cells. Involvement of guanylyl cyclase and non-guanylyl cyclase pathways. J. Biol. Chem. 276 (2001) 43668-43676
100. Levin E.R., and Frank H.J. Natriuretic peptides inhibit rat astroglial proliferation: mediation by C receptor. Am. J. Physiol. 261 (1991) R453-R457
101. Levin E.R., Frank H.J., Gelfand R., Loughlin S.E., and Kaplan G. Natriuretic peptide receptors in cultured rat diencephalon. J. Biol. Chem. 265 (1990) 10019-10024
102. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N. Engl. J. Med. 339 (1998) 321-328
103. Lucas K.A., Pitari G.M., Kazerounian S., Ruiz-Stewart I., Park J., Schulz S., Chepenik K.P., and Waldman S.A. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev. 52 (2000) 375-414
104. Maack T. Role of atrial natriuretic factor in volume control. Kidney Int. 49 (1996) 1732-1737
105. Maack T., Suzuki M., Almeida F.A., Nussenzveig D., Scarborough R.M., McEnroe G.A., and Lewicki J.A. Physiological role of silent receptors of atrial natriuretic factor. Science 238 (1987) 675-678
106. Mantyh C.R., Kruger L., Brecha N.C., and Mantyh P.W. Localization of specific binding sites for atrial natriuretic factor in the central nervous system of rat, guinea pig, cat and human. Brain Res. 412 (1987) 329-342
107. Marei H.E. Fine structural and immunohistochemical localization of cardiac hormones (ANP) in the right atrium and hypothalamus of the white rat. Eur. J. Morphol. 40 (2002) 37-41
108. Matsukawa N., Grzesik W.J., Takahashi N., Pandey K.N., Pang S., Yamauchi M., and Smithies O. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 7403-7408
109. Matsushima K., Hogan M.J., and Hakim A.M. Cortical spreading depression protects against subsequent focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 16 (1996) 221-226
110. Mattson M.P., Guo Z.H., and Geiger J.D. Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism. J. Neurochem. 73 (1999) 532-537
111. McGrath M.F., and de Bold A.J. Determinants of natriuretic peptide gene expression. Peptides 26 (2005) 933-943
112. McKenzie J.C. Atrial natriuretic peptide-like immunoreactivity in astrocytes of parenchyma and glia limitans of the canine brain. J. Histochem. Cytochem. 40 (1992) 1211-1222
113. McKenzie J.C., Berman N.E., Thomas C.R., Young J.K., Compton L.Y., Cothran L.N., Liu W.L., and Klein R.M. Atrial natriuretic peptide-like (ANP-LIR) and ANP prohormone immunoreactive astrocytes and neurons of human cerebral cortex. Glia 12 (1994) 228-243
114. McKenzie J.C., Cowie R.J., and Inagami T. ANP-like immunoreactivity in neuronal perikarya and processes associated with vessels of the pia and cerebral parenchyma in dog. Neurosci. Lett. 117 (1990) 253-258
115. McKenzie J.C., Juan Y.W., Thomas C.R., Berman N.E., and Klein R.M. Atrial natriuretic peptide-like immunoreactivity in neurons and astrocytes of human cerebellum and inferior olivary complex. J. Histochem. Cytochem. 49 (2001) 1453-1467
116. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 1197-1201
117. Misono K.S. Natriuretic peptide receptor: structure and signaling. Mol. Cell. Biochem. 230 (2002) 49-60
118. Misono K.S., Sivasubramanian N., Berkner K., and Zhang X. Expression and purification of the extracellular ligand-binding domain of the atrial natriuretic peptide (ANP) receptor: monovalent binding with ANP induces 2:2 complexes. Biochemistry 38 (1999) 516-523
119. Moodie S.A., and Martin W. Effects of cyclic nucleotides and phorbol myristate acetate on proliferation of pig aortic endothelial cells. Br. J. Pharmacol. 102 (1991) 101-106
120. Moro M.A., Fernandez-Tome P., Leza J.C., Lorenzo P., and Lizasoain I. Neuronal death induced by SIN-1 in the presence of superoxide dismutase: protection by cyclic GMP. Neuropharmacology 37 (1998) 1071-1079
121. Murthy K.S., and Makhlouf G.M. Identification of the G protein-activating domain of the natriuretic peptide clearance receptor (NPR-C). J. Biol. Chem. 274 (1999) 17587-17592
122. Murthy K.S., Teng B.Q., Zhou H., Jin J.G., Grider J.R., and Makhlouf G.M. G(i-1)/G(i-2)-dependent signaling by single-transmembrane natriuretic peptide clearance receptor. Am. J. Physiol. Gastrointest. Liver Physiol. 278 (2000) G974-G980
123. Napier M.A., Dewey R.S., Albers-Schonberg G., Bennett C.D., Rodkey J.A., Marsh E.A., Whinnery M., Seymour A.A., and Blaine E.H. Isolation and sequence determination of peptide components of atrial natriuretic factor. Biochem. Biophys. Res. Commun. 120 (1984) 981-988
124. Netchitailo P., Feuilloley M., Pelletier G., Leboulenger F., Cantin M., Gutkowska J., and Vaudry H. Atrial natriuretic factor-like immunoreactivity in the central nervous system of the frog. Neuroscience 22 (1987) 341-359
125. Oikawa S., Imai M., Inuzuka C., Tawaragi Y., Nakazato H., and Matsuo H. Structure of dog and rabbit precursors of atrial natriuretic polypeptides deduced from nucleotide sequence of cloned cDNA. Biochem. Biophys. Res. Commun. 132 (1985) 892-899
126. Oikawa S., Imai M., Ueno A., Tanaka S., Noguchi T., Nakazato H., Kangawa K., Fukuda A., and Matsuo H. Cloning and sequence analysis of cDNA encoding a precursor for human atrial natriuretic polypeptide. Nature 309 (1984) 724-726
127. Okuya S., and Yamashita H. Effects of atrial natriuretic polypeptide on rat hypothalamic neurones in vitro. J. Physiol. 389 (1987) 717-728
128. Ong H., Lazure C., Nguyen T.T., McNicoll N., Seidah N., Chretien M., and De Lean A. Bovine adrenal chromaffin granules are a site of synthesis of atrial natriuretic factor. Biochem. Biophys. Res. Commun. 147 (1987) 957-963
129. Oyama M., Kubota K., and Okamoto K. Involvement of protein kinase(s) in the intracellular signal transduction pathways for activation and adaptation of adenylate cyclase in Dictyostelium discoideum. Biochem. Biophys. Res. Commun. 167 (1990) 767-771
130. i activator sequences that inhibit adenylyl cyclase activity. J. Biol. Chem. 276 (2001) 22064-22070
131. Palaparti A., Li Y., and Anand-Srivastava M.B. Inhibition of atrial natriuretic peptide (ANP) C receptor expression by antisense oligodeoxynucleotides in A10 vascular smooth-muscle cells is associated with attenuation of ANP-C-receptor-mediated inhibition of adenylyl cyclase. Biochem. J. 346 (2000) 313-320
132. Palm D.E., Keil L.C., Sassani J.W., and Severs W.B. Immunoreactive atrial natriuretic peptide in the retina of rats and rabbits. Brain Res. 504 (1989) 142-144
133. Pan J.T., Lai C.J., and Yen S.H. Effects of natriuretic peptides and dopamine on single-unit activity of dorsomedial arcuate neurons in rat brain slices. Brain Res. 737 (1996) 78-82
134. Pandey K.N. Kinetic analysis of internalization, recycling and redistribution of atrial natriuretic factor-receptor complex in cultured vascular smooth-muscle cells. Ligand-dependent receptor down-regulation. Biochem. J. 288 Pt 1 (1992) 55-61
135. Pandey K.N. Stoichiometric analysis of internalization, recycling, and redistribution of photoaffinity-labeled guanylate cyclase/atrial natriuretic factor receptors in cultured murine Leydig tumor cells. J. Biol. Chem. 268 (1993) 4382-4390
136. Pandey K.N. Biology of natriuretic peptides and their receptors. Peptides 26 (2005) 901-932
137. Pandey K.N., Inagami T., and Misono K.S. Atrial natriuretic factor receptor on cultured Leydig tumor cells: ligand binding and photoaffinity labeling. Biochemistry 25 (1986) 8467-8472
138. Pandey K.N., Kumar R., Li M., and Nguyen H. Functional domains and expression of truncated atrial natriuretic peptide receptor-A: the carboxyl-terminal regions direct the receptor internalization and sequestration in COS-7 cells. Mol. Pharmacol. 57 (2000) 259-267
139. Pandey K.N., and Singh S. Molecular cloning and expression of murine guanylate cyclase/atrial natriuretic factor receptor cDNA. J. Biol. Chem. 265 (1990) 12342-12348
140. Papouchado M.L., Vatta M.S., Bianciotti L.G., and Fernandez B.E. Effects of atrial natriuretic factor on norepinephrine release evoked by angiotensins II and III in the rat adrenal medulla. Arch. Physiol. Biochem. 103 (1995) 55-58
141. Porter J.G., Arfsten A., Palisi T., Scarborough R.M., Lewicki J.A., and Seilhamer J.J. Cloning of a cDNA encoding porcine brain natriuretic peptide. J. Biol. Chem. 264 (1989) 6689-6692
142. Potter L.R. Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: dephosphorylation is a mechanism of desensitization. Biochemistry 37 (1998) 2422-2429
143. Potter L.R., Abbey-Hosch S., and Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr. Rev. 27 (2006) 47-72
144. Potter L.R., and Garbers D.L. Dephosphorylation of the guanylyl cyclase-A receptor causes desensitization. J. Biol. Chem. 267 (1992) 14531-14534
145. Potter L.R., and Garbers D.L. Protein kinase C-dependent desensitization of the atrial natriuretic peptide receptor is mediated by dephosphorylation. J. Biol. Chem. 269 (1994) 14636-14642
146. Potter L.R., and Hunter T. Phosphorylation of the kinase homology domain is essential for activation of the A-type natriuretic peptide receptor. Mol. Cell. Biol. 18 (1998) 2164-2172
147. Potter L.R., and Hunter T. A constitutively "phosphorylated" guanylyl cyclase-linked atrial natriuretic peptide receptor mutant is resistant to desensitization. Mol. Biol. Cell 10 (1999) 1811-1820
148. Resink T.J., Scott-Burden T., Baur U., Jones C.R., and Buhler F.R. Atrial natriuretic peptide induces breakdown of phosphatidylinositol phosphates in cultured vascular smooth-muscle cells. Eur. J. Biochem. 172 (1988) 499-505
149. Richard D., and Bourque C.W. Atrial natriuretic peptide modulates synaptic transmission from osmoreceptor afferents to the supraoptic nucleus. J. Neurosci. 16 (1996) 7526-7532
150. Richards A.M. Is atrial natriuretic factor a physiological regulator of sodium excretion? A review of the evidence. J. Cardiovasc. Pharmacol. 16 Suppl. 7 (1990) S39-S42
151. Rodriguez Fermepin M., Alvarez Maubecin V., Zarrabeitia V., Bianciotti L.G., Vatta M.S., and Fernandez B.E. Atrial natriuretic factor (ANF) effects on L-, N-, and P/Q-type voltage-operated calcium channels. Cell. Mol. Neurobiol. 22 (2002) 771-781
152. Rollin R., Mediero A., Fernandez-Cruz A., and Fernandez-Durango R. Downregulation of the atrial natriuretic peptide/natriuretic peptide receptor-C system in the early stages of diabetic retinopathy in the rat. Mol. Vis. 11 (2005) 216-224
153. Rollin R., Mediero A., Roldan-Pallares M., Fernandez-Cruz A., and Fernandez-Durango R. Natriuretic peptide system in the human retina. Mol. Vis. 10 (2004) 15-22
154. 2+ current in rat magnocellular neurosecretory cells by activating the NPR-C receptor. J. Neurophysiol. 94 (2005) 612-621
155. Rosenzweig A., and Seidman C.E. Atrial natriuretic factor and related peptide hormones. Annu. Rev. Biochem. 60 (1991) 229-255
156. Saavedra J.M., and Kurihara M. Autoradiography of atrial natriuretic peptide (ANP) receptors in the rat brain. Can. J. Physiol. Pharmacol. 69 (1991) 1567-1575
157. Saper C.B., Hurley K.M., Moga M.M., Holmes H.R., Adams S.A., Leahy K.M., and Needleman P. Brain natriuretic peptides: differential localization of a new family of neuropeptides. Neurosci. Lett. 96 (1989) 29-34
158. Saper C.B., Standaert D.G., Currie M.G., Schwartz D., Geller D.M., and Needleman P. Atriopeptin-immunoreactive neurons in the brain: presence in cardiovascular regulatory areas. Science 227 (1985) 1047-1049
159. Schulz S., Singh S., Bellet R.A., Singh G., Tubb D.J., Chin H., and Garbers D.L. The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 58 (1989) 1155-1162
160. Schulz S., Yuen P.S., and Garbers D.L. The expanding family of guanylyl cyclases. Trends Pharmacol. Sci. 12 (1991) 116-120
161. Schulz-Knappe P., Forssmann K., Herbst F., Hock D., Pipkorn R., and Forssmann W.G. Isolation and structural analysis of "urodilatin", a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin. Wochenschr. 66 (1988) 752-759
162. Schweitz H., Vigne P., Moinier D., Frelin C., and Lazdunski M. A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps). J. Biol. Chem. 267 (1992) 13928-13932
163. 125I-atrial natriuretic peptide (ANP) in the rat fetus. Anat. Embryol. (Berl.) 183 (1991) 245-249
164. Seidah N.G., Lazure C., Chretien M., Thibault G., Garcia R., Cantin M., Genest J., Nutt R.F., Brady S.F., Lyle T.A., et al. Amino acid sequence of homologous rat atrial peptides: natriuretic activity of native and synthetic forms. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 2640-2644
165. Seidman C.E., Bloch K.D., Klein K.A., Smith J.A., and Seidman J.G. Nucleotide sequences of the human and mouse atrial natriuretic factor genes. Science 226 (1984) 1206-1209
166. Seilhamer J.J., Arfsten A., Miller J.A., Lundquist P., Scarborough R.M., Lewicki J.A., and Porter J.G. Human and canine gene homologs of porcine brain natriuretic peptide. Biochem. Biophys. Res. Commun. 165 (1989) 650-658
167. Sellitti D.F., Perrella G., Doi S.Q., and Curcio F. Natriuretic peptides increase cAMP production in human thyrocytes via the natriuretic peptide clearance receptor (NPR-C). Regul. Pept. 97 (2001) 103-109
168. Sharma R.K., Yadav P., and Duda T. Allosteric regulatory step and configuration of the ATP-binding pocket in atrial natriuretic factor receptor guanylate cyclase transduction mechanism. Can. J. Physiol. Pharmacol. 79 (2001) 682-691
169. Silberbach M., and Roberts Jr. C.T. Natriuretic peptide signalling: molecular and cellular pathways to growth regulation. Cell. Signal. 13 (2001) 221-231
170. Simonnet G., Allard M., Legendre P., Gabrion J., and Vincent J.D. Characteristics and specific localization of receptors for atrial natriuretic peptides at non-neuronal cells in cultured mouse spinal cord cells. Neuroscience 29 (1989) 189-199
171. Simpson P.J., Miller I., Moon C., Hanlon A.L., Liebl D.J., and Ronnett G.V. Atrial natriuretic peptide type C induces a cell-cycle switch from proliferation to differentiation in brain-derived neurotrophic factor- or nerve growth factor-primed olfactory receptor neurons. J. Neurosci. 22 (2002) 5536-5551
172. Skofitsch G., and Jacobowitz D.M. Atrial natriuretic peptide in the central nervous system of the rat. Cell. Mol. Neurobiol. 8 (1988) 339-391
173. Skofitsch G., Jacobowitz D.M., Eskay R.L., and Zamir N. Distribution of atrial natriuretic factor-like immunoreactive neurons in the rat brain. Neuroscience 16 (1985) 917-948
174. Standaert D.G., Cechetto D.F., Needleman P., and Saper C.B. Inhibition of the firing of vasopressin neurons by atriopeptin. Nature 329 (1987) 151-153
175. Standaert D.G., Needleman P., and Saper C.B. Organization of atriopeptin-like immunoreactive neurons in the central nervous system of the rat. J. Comp. Neurol. 253 (1986) 315-341
176. Stults J.T., O'Connell K.L., Garcia C., Wong S., Engel A.M., Garbers D.L., and Lowe D.G. The disulfide linkages and glycosylation sites of the human natriuretic peptide receptor-C homodimer. Biochemistry 33 (1994) 11372-11381
177. Sudoh T., Kangawa K., Minamino N., and Matsuo H. A new natriuretic peptide in porcine brain. Nature 332 (1988) 78-81
178. Sudoh T., Minamino N., Kangawa K., and Matsuo H. Brain natriuretic peptide-32: N-terminal six amino acid extended form of brain natriuretic peptide identified in porcine brain. Biochem. Biophys. Res. Commun. 155 (1988) 726-732
179. Sudoh T., Minamino N., Kangawa K., and Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun. 168 (1990) 863-870
180. Suga S., Nakao K., Hosoda K., Mukoyama M., Ogawa Y., Shirakami G., Arai H., Saito Y., Kambayashi Y., Inouye K., et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130 (1992) 229-239
181. Sumners C., and Tang W. Atrial natriuretic peptide receptor subtypes in rat neuronal and astrocyte glial cultures. Am. J. Physiol. 262 (1992) C1134-C1143
182. Takahashi K., Totsune K., Sone M., Ohneda M., Murakami O., Itoi K., and Mouri T. Human brain natriuretic peptide-like immunoreactivity in human brain. Peptides 13 (1992) 121-123
183. Takekoshi K., Ishii K., Isobe K., Nomura F., Nammoku T., and Nakai T. Effects of natriuretic peptides (ANP, BNP, CNP) on catecholamine synthesis and TH mRNA levels in PC12 cells. Life Sci. 66 (2000) PL303-PL311
184. Takida S., Elmquist B.J., and Trachte G.J. C-type natriuretic peptide attenuates evoked dopamine efflux by influencing Goalpha. Hypertension 33 (1999) 124-129
185. Tanaka I., Misono K.S., and Inagami T. Atrial natriuretic factor in rat hypothalamus, atria and plasma: determination by specific radioimmunoassay. Biochem. Biophys. Res. Commun. 124 (1984) 663-668
186. Tang W., Paulding W.R., and Sumners C. ANP receptors in neurons and astrocytes from spontaneously hypertensive rat brain. Am. J. Physiol. 265 (1993) C106-C112
187. Teoh R., Kum W., Cockram C.S., Young J.D., and Nicholls M.G. Mouse astrocytes possess specific ANP receptors which are linked to cGMP production. Clin. Exp. Pharmacol. Physiol. 16 (1989) 323-327
188. Tian M., and Yang X.L. C-type natriuretic peptide modulates glutamate receptors on cultured rat retinal amacrine cells. Neuroscience 139 (2006) 1211-1220
189. Tong Y., and Pelletier G. Ontogeny of atrial natriuretic factor (ANF) binding in various areas of the rat brain. Neuropeptides 16 (1990) 63-68
190. Trachte G. Neuronal regulation and function of natriuretic peptide receptor C. Peptides 26 (2005) 1060-1067
191. Trachte G.J. Depletion of natriuretic peptide C receptors eliminates inhibitory effects of C-type natriuretic peptide on evoked neurotransmitter efflux. J. Pharmacol. Exp. Ther. 294 (2000) 210-215
192. Trachte G.J. Natriuretic peptides suppress protein kinase C activity to reduce evoked dopamine efflux from pheochromocytoma (PC12) cells. Endocrinology 144 (2003) 94-100
193. Trachte G.J., and Drewett J.G. C-type natriuretic peptide neuromodulates independently of guanylyl cyclase activation. Hypertension 23 (1994) 38-43
194. Ueda S., Minamino N., Sudoh T., Kangawa K., and Matsuo H. Regional distribution of immunoreactive brain natriuretic peptide in porcine brain and spinal cord. Biochem. Biophys. Res. Commun. 155 (1988) 733-739
195. Ullrich A., and Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 61 (1990) 203-212
196. Valli N., Gobinet A., and Bordenave L. Review of 10 years of the clinical use of brain natriuretic peptide in cardiology. J. Lab. Clin. Med. 134 (1999) 437-444
197. Vanderheyden M., Bartunek J., and Goethals M. Brain and other natriuretic peptides: molecular aspects. Eur. J. Heart Fail. 6 (2004) 261-268
198. Vatta M., Papouchado M., Bianciotti L., Locatelli A., and Fernandez B. Atrial natriuretic factor modifies noradrenaline release in a sodium-free medium. J. Auton. Pharmacol. 14 (1994) 267-273
199. Vatta M., Rodriguez-Fermepin M., Bianciotti L., Perazzo J., Monserrat A., and Fernandez B. Atrial natriuretic factor enhances norepinephrine uptake in circumventricular organs, locus coeruleus and nucleus tractus solitarii of the rat. Neurosci. Lett. 197 (1995) 29-32
200. Vatta M., Travaglianti M., Bianciotti L., Coll C., Perazzo J., and Fernandez B. Atrial natriuretic factor effects on norepinephrine uptake in discrete telencephalic and diencephalic nuclei of the rat. Brain Res. 646 (1994) 324-326
201. Vatta M.S., Presas M., Bianciotti L.G., Zarrabeitia V., and Fernandez B.E. B and C types natriuretic peptides modulate norepinephrine uptake and release in the rat hypothalamus. Regul. Pept. 65 (1996) 175-184
202. Vatta M.S., Rodriguez-Fermepin M., Durante G., Bianciotti L.G., and Fernandez B.E. Atrial natriuretic factor inhibits norepinephrine biosynthesis and turnover in the rat hypothalamus. Regul. Pept. 85 (1999) 101-107
203. Vesely D.L. Atrial natriuretic peptide prohormone gene expression: hormones and diseases that upregulate its expression. IUBMB Life 53 (2002) 153-159
204. Vieira M.A., Gao M., Nikonova L.N., and Maack T. Molecular and cellular physiology of the dissociation of atrial natriuretic peptide from guanylyl cyclase a receptors. J. Biol. Chem. 276 (2001) 36438-36445
205. Vlasuk G.P., Miller J., Bencen G.H., and Lewicki J.A. Structure and analysis of the bovine atrial natriuretic peptide precursor gene. Biochem. Biophys. Res. Commun. 136 (1986) 396-403
206. Vles J.S., de Louw A.J., Steinbusch H., Markerink-van Ittersum M., Steinbusch H.W., Blanco C.E., Axer H., Troost J., and de Vente J. Localization and age-related changes of nitric oxide- and ANP-mediated cyclic-GMP synthesis in rat cervical spinal cord: an immunocytochemical study. Brain Res. 857 (2000) 219-234
207. Waschek J.A. Developmental actions of natriuretic peptides in the brain and skeleton. Cell. Mol. Life Sci. 61 (2004) 2332-2342
208. Wiggins A.K., Shen P.J., and Gundlach A.L. Atrial natriuretic peptide expression is increased in rat cerebral cortex following spreading depression: possible contribution to sd-induced neuroprotection. Neuroscience 118 (2003) 715-726
209. Wilcox J.N., Augustine A., Goeddel D.V., and Lowe D.G. Differential regional expression of three natriuretic peptide receptor genes within primate tissues. Mol. Cell. Biol. 11 (1991) 3454-3462
210. Wolfensberger T.J., Holz F.G., Ationu A., Carter N.D., and Bird A.C. Natriuretic peptides and their receptors in human neural retina and retinal pigment epithelium. Ger. J. Ophthalmol. 3 (1994) 248-252
211. Yamamoto S., Morimoto I., Yanagihara N., Kangawa K., Inenaga K., Eto S., and Yamashita H. C-type natriuretic peptide suppresses arginine-vasopressin secretion from dissociated magnocellular neurons in newborn rat supraoptic nucleus. Neurosci. Lett. 229 (1997) 97-100
212. Yamauchi T., Kashii S., Yasuyoshi H., Zhang S., Honda Y., Ujihara H., and Akaike A. Inhibition of glutamate-induced nitric oxide synthase activation by dopamine in cultured rat retinal neurons. Neurosci. Lett. 347 (2003) 155-158
213. Yanamoto H., Hashimoto N., Nagata I., and Kikuchi H. Infarct tolerance against temporary focal ischemia following spreading depression in rat brain. Brain Res. 784 (1998) 239-249
214. Yeung V.T., Mak A.S., Chui Y.L., Ho S.K., Lai K.N., Nicholls M.G., and Cockram C.S. Identification of C-type natriuretic peptide gene transcripts in glial cells. Neuroreport 7 (1996) 1709-1712
215. Yu Y.C., Cao L.H., and Yang X.L. Modulation by brain natriuretic peptide of GABA receptors on rat retinal ON-type bipolar cells. J. Neurosci. 26 (2006) 696-707
216. Zamir N., Skofitsch G., Eskay R.L., and Jacobowitz D.M. Distribution of immunoreactive atrial natriuretic peptides in the central nervous system of the rat. Brain Res. 365 (1986) 105-111
217. Zhang G., Liu Y., Ruoho A.E., and Hurley J.H. Structure of the adenylyl cyclase catalytic core. Nature 386 (1997) 247-253
218. Zhou H., and Murthy K.S. Identification of the G protein-activating sequence of the single-transmembrane natriuretic peptide receptor C (NPR-C). Am. J. Physiol. Cell Physiol. 284 (2003) C1255-C1261
219. Zorad S., Tsutsumi K., Bhatia A.J., and Saavedra J.M. Localization and characteristics of atrial natriuretic peptide receptors in prenatal and postnatal rat brain. Eur. J. Pharmacol. 241 (1993) 195-200